Acute liver injury in a non-alcoholic fatty liver disease patient with chloroform exposure: a case report

被引:0
|
作者
Yosuke Suehiro
Takuro Uchida
Masataka Tsuge
Eisuke Murakami
Daiki Miki
Tomokazu Kawaoka
Michio Imamura
Hiroshi Aikata
Koji Arihiro
Shiro Oka
机构
[1] Hiroshima University,Department of Gastroenterology, Graduate School of Biomedical and Health Sciences
[2] Hiroshima University,Natural Science Center for Basic Research and Development
[3] Hiroshima University Hospital,Department of Pathology
来源
关键词
Acute liver injury; Non-alcoholic steatohepatitis; Chloroform exposure;
D O I
暂无
中图分类号
学科分类号
摘要
We report a rare case of acute liver injury by daily exposure to small amounts of chloroform in non-alcoholic fatty liver disease (NAFLD) patient. The patient had been followed up in our hospital every 3 months. Although his alanine aminotransferase (ALT) levels were steady around 30 ~ 60 U/L until August 2014, ALT level was spontaneously increased to more than 1,000 U/L at the follow-up point in late August 2014. As he was diagnosed as acute liver injury by chloroform exposure, we withdrew him from the exposure of chloroform and treated him with 600 mg/day of ursodeoxycholic acid. Afterwards, his ALT level rapidly improved and normalized within 1 month. To verify the influences of chloroform exposure, we measured plasma chloroform levels by gas chromatography. Although plasma chloroform concentration was 7.1 ng/ml (normal range: < 0.2 ng/ml) at the time of liver injury, the concentration had decreased to 0.7 ng/ml by 1 month later. Despite the fact that he had put on a face mask to protect from aspiration of chloroform, liver injury still occurred in the present case. Chloroform has a high solubility for lipids and accumulation of lipids in the liver might become a risk factor for liver injury by chloroform.
引用
收藏
页码:250 / 253
页数:3
相关论文
共 50 条
  • [21] Non-alcoholic fatty liver disease
    Brent A. Neuschwander-Tetri
    BMC Medicine, 15
  • [22] Non-alcoholic fatty liver disease
    Alba, LM
    Lindor, K
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2003, 17 (08) : 977 - 986
  • [23] Non-alcoholic fatty liver disease
    Sattar, Naveed
    Forrest, Ewan
    Preiss, David
    BMJ-BRITISH MEDICAL JOURNAL, 2014, 349
  • [24] Non-alcoholic fatty liver disease
    Li, Wenhao
    Alazawi, William
    CLINICAL MEDICINE, 2020, 20 (05) : 509 - 512
  • [25] Liver Cancer in a Patient with Non-cirrhotic Non-alcoholic Fatty Liver Disease
    Ziud, Hassan
    Yee, Claudine
    Kaseer, Belal
    DeNucci, Thomas
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2016, 111 : S859 - S860
  • [26] Non-alcoholic fatty liver disease and liver secretome
    Khan, Muhammad Sohaib
    Lee, Choongho
    Kim, Sang Geon
    ARCHIVES OF PHARMACAL RESEARCH, 2022, 45 (12) : 938 - 963
  • [27] Non-alcoholic fatty liver disease and liver transplantation
    Khan, Reenam S.
    Newsome, Philip N.
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2016, 65 (08): : 1208 - 1223
  • [28] Liver transplantation for non-alcoholic fatty liver disease
    Germani, Giacomo
    Becchetti, Chiara
    MINERVA GASTROENTEROLOGICA E DIETOLOGICA, 2018, 64 (02) : 138 - 146
  • [29] Liver transplantation and non-alcoholic fatty liver disease
    Zezos, Petros
    Renner, Eberhard L.
    WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (42) : 15532 - 15538
  • [30] Parental non-alcoholic fatty liver disease increases risk of non-alcoholic fatty liver disease in offspring
    Long, Michelle T.
    Gurary, Ellen B.
    Massaro, Joseph M.
    Ma, Jiantao
    Hoffmann, Udo
    Chung, Raymond T.
    Benjamin, Emelia J.
    Loomba, Rohit
    LIVER INTERNATIONAL, 2019, 39 (04) : 740 - 747